Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual carboxylic ionization driven MCC/MAA/IA hydrogels for enhanced oral insulin delivery.

International journal of pharmaceutics·2026
Same author

Sertraline Enhances Bacterial Control without Adversely Affecting the Pharmacodynamic-Pharmacokinetic Properties of Frontline Tuberculosis Drugs.

ACS pharmacology & translational science·2026
Same author

A Secret Worth Telling: The Salivary Secret (Ory) Affair.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same author

A comparison of AIROD and conventional bougie as an intubation guide in simulated difficult airway: A prospective randomized study.

Journal of anaesthesiology, clinical pharmacology·2026
Same author

Comparison of fiberoptic-guided success of intubation using intubating LMA and intubating laryngeal tube suction.

Journal of anaesthesiology, clinical pharmacology·2026
Same author

Pharmacological inhibition of both DGKα and DGKζ is required for optimal T cell activation.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Deciphering Physicochemical Properties of Urinary Proteins from Stone Formers as Macromolecular Prolithogenic Factors to Drive Calcium Oxalate Stone Development.

ACS omega·2026
Same journal

Impact of an Artificial Albumin Corona on Surface Charge-Driven Nano-Bio Interactions and Cytotoxicity of Silver Nanoparticles.

ACS omega·2026
Same journal

Structural and Functional Disruption of Thiopurine S‑Methyltransferase by the A80P Variant: A Simulation and Genotyping Study.

ACS omega·2026
Same journal

CRISPR/Cas12a2-Mediated Ultrasensitive Assay for Rapid Detection of H1N1 Influenza Virus RNA.

ACS omega·2026
Same journal

Photocatalytic Treatment of Real Sugar Industry Wastewater Using Lignocellulosic Biomass-Derived Hydrochar/g-CN.

ACS omega·2026
Same journal

Electrochemical Dopamine Biosensor Based on Plant-Derived Peroxidase Immobilized on Titanate Nanowires.

ACS omega·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.0K

Enhancing Photodynamic Therapy through Magnetic Targeting: A Biochemical Perspective.

Kritika1,2, Monika Yadav3, Mansi Malik3

  • 1Department of Chemistry, University of Delhi, Delhi 110007, India.

ACS Omega
|June 9, 2025
PubMed
Summary
This summary is machine-generated.

Magnetic nanoparticles (MNPs) loaded with methylene blue enhance photodynamic therapy for breast cancer by inducing oxidative and nitrosative stress. This targeted approach significantly boosts cancer cell death with minimal side effects.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Related Experiment Videos

Last Updated: Jul 5, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.0K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Oncology

Background:

  • Magnetic nanoparticles (MNPs) offer potential for targeted drug delivery in cancer therapy.
  • Magnetically targeted photodynamic therapy (MT-PDT) combines magnetic targeting with photodynamic therapy for enhanced efficacy.
  • Understanding the biochemical mechanisms of MT-PDT is crucial for optimizing treatment and minimizing side effects.

Purpose of the Study:

  • To investigate the biochemical mechanisms, specifically oxidative and nitrosative stress, induced by MNPs in MT-PDT.
  • To synthesize and characterize methylene-blue-loaded cobalt ferrite nanoparticles (MB-SCFNP) for MT-PDT.
  • To evaluate the efficacy and underlying mechanisms of MB-SCFNP-mediated MT-PDT in breast cancer models.

Main Methods:

  • Synthesis and characterization of methylene-blue-loaded cobalt ferrite nanoparticles (MB-SCFNP).
  • In vitro evaluation of MB-SCFNP cytotoxicity under laser irradiation with and without a static magnetic field.
  • Biochemical assays to assess reactive oxygen species (ROS), reactive nitrogen species (RNS), lactate dehydrogenase (LDH) release, and superoxide dismutase (SOD) levels.

Main Results:

  • MB-SCFNP demonstrated significantly higher cytotoxicity in the presence of a static magnetic field and laser compared to laser alone, with a 2-fold lower IC50.
  • Minimal dark toxicity of MB-SCFNP indicated good cytocompatibility.
  • MB-SCFNP-mediated apoptosis involved enhanced intracellular ROS production, and biochemical assays confirmed an imbalance in ROS/RNS and antioxidant defenses, indicating oxido-nitrosative stress.

Conclusions:

  • MB-SCFNP are effective in MT-PDT for breast cancer, significantly enhancing cell death through induced oxido-nitrosative stress.
  • The study elucidates the biochemical pathways, including ROS and RNS generation, involved in MB-SCFNP-mediated MT-PDT.
  • These findings provide critical insights for optimizing MT-PDT protocols for breast cancer treatment using magnetic nanoparticles.